BioSpace News Archive

Berkeley Lights, Inc. and Novo Nordisk today announced that Novo Nordisk has purchased the Beacon® Optofluidic platform to accelerate workflows in cell line development and to use the platform for future protein and antibody discovery.

On December 7, 2018 at the Loews Regency Hotel in San Francisco, The Academy of Supra-gingival Healthy Dentistry held its first Annual Meeting to a full room of over 70 dentist and dental professionals, all very excited to learn the latest on how, Supra-gingival Healthy Dentistry can provide truly healthier biocompatible dentistry for their patients.

Apexian Pharmaceuticals is shedding light on the question of how pre-leukemic cells transform into full-blown leukemia.

Hawaii is the healthiest state in 2018; Louisiana faces most challenges

Checkmate Pharmaceuticals, a clinical stage biopharmaceutical company focused upon activation of innate immunity to treat advanced cancer, has appointed Barry Labinger as President and CEO. Arthur M. Krieg, MD, Checkmate’s founder and current President and CEO, will assume the newly-created role of Chief Scientific Officer.

X-Chem, Inc. (X-Chem), a privately held biotechnology company applying its innovative drug discovery platform to the generation of novel small molecule therapeutics, announced today a drug discovery partnership with Almirall, S.A. (Almirall) to discover lead compounds for innovative and challenging targets with dermatology applications.

Tvardi Therapeutics Inc. (“Tvardi”), a privately held, clinical-stage biopharmaceutical company focused on the development of STAT3 inhibitors, today announced the appointment of Imran Alibhai, Ph.D. as Chief Executive Officer and a member of the Board of Directors, effective immediately.

InGeneron reports positive top-line data from its clinical lead program in rotator cuff tendinopathy paving the way for a pivotal study in 2019.

Altasciences recently completed an important First-in-Human (FIH), Phase I, integrated adaptive clinical trial, including single and multiple ascending doses (SAD and MAD), Project Management, Bioanalysis, and Medical Writing, for sponsor Bellus Health.

DarioHealth’s Digital Diabetes Content and Coaching, powered by LMC, to be made available across Canada starting in Q12019